Antithrombin III for critically ill patients

Background Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti‐inflammatory properties but the efficacy and any harmful effects of AT III supplementation in cri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2016-02, Vol.2018 (12), p.CD005370
Hauptverfasser:	Allingstrup, Mikkel, Wetterslev, Jørn, Ravn, Frederikke B, Møller, Ann Merete, Afshari, Arash
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Anticoagulants Anticoagulants - adverse effects Anticoagulants - therapeutic use Antithrombin III Antithrombin III - adverse effects Antithrombin III - therapeutic use Anti‐Inflammatory Agents Child health Coagulation and bleed management Critical Illness Critical Illness - mortality Humans Infectious disease Medicine General & Introductory Medical Sciences Pain & anaesthesia Post‐anaesthetic unit/intensive care unit Randomized Controlled Trials as Topic Sepsis & critical care
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!